What’s Wrong with Beard the Boxer Mix?
Molecular Diagnostics Held the Key to Getting His Urinary Tract Back on Track.
Signalment
Beard: 13-year-old neutered male boxer mix
Location: Estes Park, CO
Background: Beard, presented with acute onset of moderate serous preputial discharge.
Primary Vet: Cara Woodford, DVM, MS, cVMA
Case Details and History
Beard, a 13-year-old neutered male boxer mix, presented with acute onset of moderate serous preputial discharge. Two months earlier, he’d been treated with antibiotics for purulent preputial discharge, which seemed to resolve. Otherwise, he’d been doing well at home.
On presentation, Beard was bright, alert, and responsive (BAR). And aside from the persistent discharge, his physical examination was normal.
Diagnostic Testing
Beard’s bloodwork was unremarkable, but the urinalysis revealed severe hematuria, moderate proteinuria, pyuria, bacteriuria, and hyposthenuria.
Abdominal ultrasound showed significant prostatomegaly, with a mottled and mineralized appearance. Thoracic and abdominal radiographs were within normal limits (WNL), with no evidence of metastasis.
Given the nature of the prostate and the difficulty of sampling (i.e., potential blood contamination; need for sedation; and ultrasound–guided biopsy), we opted for the CADET™ BRAF test as the next diagnostic step. This simple urine test detects bladder, urinary and prostate cancer in dogs.
Diagnosis and Treatment
The results confirmed a diagnosis of transitional cell carcinoma (TCC).
We immediately started Beard on oral chemotherapy and piroxicam. However, piroxicam elevated Beard’s renal values and had to be discontinued.
Beard has been doing well over the past eight months, with no recurrence of clinical signs. Despite the challenging diagnosis, his owner appreciated that CADET™ BRAF was noninvasive and could accurately identify both bladder and prostate carcinoma without sedation.
What is CADET™ BRAF?
The CADET™ BRAF test is a noninvasive assessment for dogs displaying clinical signs consistent with transitional cell carcinoma, also known as urothelial carcinoma (TCC/UC).
CADET™ BRAF evaluates canine urine samples for the presence of cells containing a mutation for TCC/UC, the most common type of canine bladder/prostate cancer. This test’s innovative technology is accurate, affordable, and convenient for both veterinarian and pet owner.
Bring Noninvasive TCC/UC Detection to Your Practice
Contact your Antech Sales Representative or call:
800–872–1001 (U.S.)
800–341–3440 (Canada)
Product Information
| US CODE | CANADA CODE | SPECIMEN | VOLUME |
| T1025 | CT1025 | CADET™ BRAF urine container | 40 ml free-catch urine |
TURNAROUND TIME
3–6 days
Find CADET™ BRAF in HealthTracks™
© 2025 Antech Diagnostics, Inc. All rights reserved. Antech, Antech logo, and all other trademarks used herein are the trademarks of Antech Diagnostics, Inc. or its affiliates. 050725
